Location History:
- Suita, JP (2022)
- Osaka, JP (2022 - 2024)
- Ibaraki, JP (2024)
Company Filing History:
5 out of 987 
4 out of 21 
1 out of 1 
Years Active: 2022-2024
Title: Innovations of Yuya Kasahara
Introduction
Yuya Kasahara is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biomedical innovation, particularly in the development of antisense oligonucleic acids. With a total of six patents to his name, his work focuses on reducing hepatotoxicity and targeting specific molecules for antitumor effects.
Latest Patents
One of his latest patents involves an antisense oligonucleic acid designed to minimize hepatotoxicity. This invention is characterized by a base length of not less than 7 nucleotides and not more than 30 nucleotides. The design includes 2',4′-bridged nucleic acids at both terminals, with modified nucleic acid residues in between. Another significant patent is an antisense oligonucleotide targeting the ARL4C molecule, which aims to exert an antitumor effect in vivo. This oligonucleotide can inhibit the expression of ARL4C in tumor cells and suppress their migration and proliferation.
Career Highlights
Yuya Kasahara has worked with esteemed institutions such as Osaka University and the National Institutes of Biomedical Innovation, Health and Nutrition. His research has contributed to advancements in nucleic acid drugs and therapeutic applications.
Collaborations
Some of his notable coworkers include Satoshi Obika and Reiko Waki. Their collaborative efforts have furthered the research and development of innovative biomedical solutions.
Conclusion
Yuya Kasahara's work in the field of antisense oligonucleic acids showcases his commitment to advancing medical science. His inventions hold promise for improving treatment options for various diseases, particularly in oncology.